Amtagvi Approval Boosts Iovance Biotherapeutics (IOVA), Rally Sustainability Questioned

The approval of Amtagvi has boosted Iovance Biotherapeutics, Inc. (IOVA) stock, but the article questions whether this rally can be sustained in the long term.